A Spokane father is facing a devastating choice between financial ruin and his life as he battles an extremely rare disease ...
For months, an experimental medication has kept him alive, but the clinical trial that provided it is losing its funding.
SPOKANE, Wash. – Ryan Becker, a Spokane resident, is battling an extremely rare skin condition known as pyoderma gangrenosum. After visits to the Mayo Clinic and Johns Hopkins, Becker has been ...
InflaRx N.V. (NASDAQ:IFRX) on Wednesday announced that the Independent Data Monitoring Committee (IDMC) conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma ...
His family says they have exhausted every option — contacting lawmakers, drug manufacturers, and journalists — and are now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback